A volunteer in CureVac’s clinical trial received a shot in Brussels in March.Credit...Yves Herman/Reuters In early 2020, dozens of scientific teams scrambled to make a vaccine for Covid-19. Some chose tried-and-true techniques, such as making vaccines from killed viruses. But a handful of companies bet on a riskier method, one that had never produced a licensed vaccine: deploying a genetic molecul